Qudratus Lumborum Block for Postoperative Pain After Endoscopic Prostatectomy.
NCT ID: NCT03600129
Last Updated: 2019-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2018-07-25
2019-10-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Analgesic Effect of QLB II After Robotic Prostatectomy. (QLB II: Quadratus Lomborum Block II Type)
NCT03941899
Postoperative Pain Management Following Robotic Assisted Sacrocolpopexy
NCT06309693
Ultrasound Guided Posterior Quadratus Lumborum Block for Postoperative Analgesia in Gynecologic Surgery
NCT04549090
Impact of Preoperative Quadratus Lumborum Block on Postoperative Opioid Consumption After Laparoscopic Hysterectomy
NCT06709716
Volume vs Concentration: Quadratus Lumborum Blocks With High Volume/Low Concentration or Low Volume/ High Concentration in Nephrectomies
NCT04077398
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
QLB with 0,375% ropivacaine
Qadratus Lumborum Block
Bilateral, ultrasound - guided Quadratus Lumborum Block
30 milliliters of 0.375% Ropivacaine
30 milliliters of 0.375% Ropivacaine used for Quadratus Lumborum Block
QLB with 0,9% NaCl
Qadratus Lumborum Block
Bilateral, ultrasound - guided Quadratus Lumborum Block
30 milliliters of 0.9% NaCl
30 milliliters of 0.9% NaCl used for Quadratus Lumborum Block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Qadratus Lumborum Block
Bilateral, ultrasound - guided Quadratus Lumborum Block
30 milliliters of 0.375% Ropivacaine
30 milliliters of 0.375% Ropivacaine used for Quadratus Lumborum Block
30 milliliters of 0.9% NaCl
30 milliliters of 0.9% NaCl used for Quadratus Lumborum Block
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for transperitoneal or extraperitoneal endoscopic prostatectomy
* Able to understand information provided and to sign the informed consent for participation in the study
Exclusion Criteria
* infection in the area of block placement
* known chronic use of opioids, gabapentinoids and tricyclic antidepressants
* mental inability to understand the principles and rules of patient-controlled analgesia pump
40 Years
80 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre of Postgraduate Medical Education
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bartosz Horosz, MD
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malgorzata Malec-Milewska, MD, PhD
Role: STUDY_CHAIR
Orlowski Hospital, Centre of Postgraduate Medical Education, Department of Anesthesiology and Intensive Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre of Postgraduate Medical Education,Department of Anesthesia and Intensive Care
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
83/PB/2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.